13F-HR filed by Frazier Life Sciences Management, L.P.
Frazier Life Sciences Management, L.P. filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 50 holding rows worth $2,369,980,836.
- Accession
- 0001892134-24-000003
- Filer
- CIK 1892134
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 50 entries on the cover page, a total value of $2,369,980,836 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,369,980,836 with VALUE read as dollars as filed, 13F file number 028-22504. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 12,226,943 | $289,167,202 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 988,460 | $175,876,688 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 6,495,392 | $163,164,247 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 9,781,472 | $162,665,879 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 3,131,008 | $124,113,157 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 10,109,279 | $107,360,543 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 3,415,604 | $105,610,476 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 2,190,179 | $94,900,456 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 8,785,284 | $87,062,164 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,139,405 | $77,832,756 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,787,527 | $64,976,606 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,303,567 | $60,257,062 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 4,142,855 | $56,964,256 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 885,165 | $52,029,999 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 785,000 | $48,874,100 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,014,349 | $48,500,875 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 3,687,867 | $43,738,103 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,561,230 | $42,059,536 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 875,667 | $37,478,548 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 2,471,704 | $36,383,483 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,204,867 | $35,627,917 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 770,000 | $33,803,000 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 746,479 | $33,613,949 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 997,455 | $32,147,975 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 4,623,324 | $29,496,807 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 629,194 | $26,967,255 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 7,381,090 | $25,464,761 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,148,591 | $24,809,566 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,455,837 | $22,900,316 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 1,502,788 | $22,090,984 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 899,700 | $20,261,244 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 4,000,000 | $19,920,000 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 393,000 | $16,612,110 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 523,166 | $15,297,374 | dollars as filed | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,069,244 | $15,119,110 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 2,816,294 | $14,926,358 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 832,220 | $13,648,408 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,952,857 | $13,279,428 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 2,867,750 | $12,818,843 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 285,331 | $11,778,464 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 1,000,000 | $11,640,000 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 470,338 | $8,696,550 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 936,576 | $6,293,791 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 203,684 | $5,603,347 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 500,333 | $5,523,676 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 1,388,889 | $4,513,889 | dollars as filed | |
| METAGENOMI THERAPEUTICS INC | 59102M104 | COM | 279,025 | $2,943,714 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 1,030,878 | $2,649,356 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 1,709,907 | $2,188,681 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 264,377 | $327,827 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892134-24-000003 | this filing | 2024-05-15 | acceptance time not in the bulk data set |